X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (203) 203
Publication (30) 30
Book / eBook (2) 2
Book Chapter (2) 2
Book Review (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Patent (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
index medicus (64) 64
gastroenterology & hepatology (63) 63
crohn's disease (45) 45
male (37) 37
female (35) 35
inflammatory-bowel-disease (34) 34
adult (29) 29
inflammatory bowel disease (27) 27
middle aged (26) 26
crohn disease - drug therapy (25) 25
infliximab (24) 24
ulcerative colitis (22) 22
crohns-disease (20) 20
ulcerative-colitis (20) 20
gastroenterology and hepatology (19) 19
azathioprine (17) 17
risk factors (17) 17
young adult (17) 17
aged (16) 16
crohn disease - complications (16) 16
adolescent (15) 15
immunosuppressive agents - therapeutic use (14) 14
paper (14) 14
prevalence (14) 14
treatment outcome (14) 14
animals (13) 13
antibodies, monoclonal - therapeutic use (13) 13
double-blind (13) 13
aged, 80 and over (12) 12
methotrexate (12) 12
review (12) 12
anti-inflammatory agents, non-steroidal - therapeutic use (11) 11
cohort studies (11) 11
diagnosis (11) 11
risk-factors (11) 11
switzerland (11) 11
therapy (11) 11
analysis (10) 10
colitis, ulcerative - drug therapy (10) 10
crohn disease - therapy (10) 10
switzerland - epidemiology (10) 10
tumor necrosis factor-alpha - antagonists & inhibitors (10) 10
certolizumab pegol (9) 9
cohort (9) 9
crohn disease - diagnosis (9) 9
crohn disease - pathology (9) 9
drug therapy, combination (9) 9
life sciences (9) 9
management (9) 9
natural-history (9) 9
adalimumab (8) 8
anti-bacterial agents - therapeutic use (8) 8
crohn disease - surgery (8) 8
extraintestinal manifestations (8) 8
glucocorticoids - therapeutic use (8) 8
inflammatory bowel diseases (8) 8
placebo-controlled trial (8) 8
prospective studies (8) 8
quality-of-life (8) 8
retrospective studies (8) 8
severity of illness index (8) 8
surgery (8) 8
appropriateness (7) 7
child (7) 7
follow-up (7) 7
intestine (7) 7
mice (7) 7
safety (7) 7
steroids (7) 7
surveys and questionnaires (7) 7
time factors (7) 7
care and treatment (6) 6
colon (6) 6
crohn's disease, therapy (6) 6
disease progression (6) 6
gastrointestinal agents - therapeutic use (6) 6
immunologic factors - therapeutic use (6) 6
immunology (6) 6
inflammatory bowel diseases - immunology (6) 6
medical research (6) 6
mycophenolate-mofetil (6) 6
pharmacology & pharmacy (6) 6
pregnancy (6) 6
recurrence (6) 6
remission (6) 6
urology & nephrology (6) 6
610 medicine & health (5) 5
anti-inflammatory agents - therapeutic use (5) 5
child, preschool (5) 5
clinical-course (5) 5
crohn disease - epidemiology (5) 5
efficacy (5) 5
epidemiology (5) 5
in-vitro (5) 5
inflammatory bowel diseases - drug therapy (5) 5
intestinal inflammation (5) 5
intestinal obstruction - etiology (5) 5
intravenous cyclosporine (5) 5
maintenance therapy (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, 1. Aufl., Engineering materials, ISBN 9781447140139, viii, 412 p. :ill. (some col.)
Bimetallic nanoparticles, also called nanoalloys, are at the heart of nanoscience because of their ability to tune together composition and size for specific... 
Nanostructured materials | Nanotechnology | Alloys | Industrial chemistry & manufacturing technologies
Book
by Yilmaz, Bahtiyar and Juillerat, Pascal and Øyås, Ove and Ramon, Charlotte and Bravo, Francisco Damian and Franc, Yannick and Fournier, Nicolas and Michetti, Pierre and Mueller, Christoph and Geuking, Markus and Pittet, Valerie E. H and Maillard, Michel H and Rogler, Gerhard and Abdelrahman, Karim and Ademi, Gentiana and Aepli, Patrick and Thomas, Amman and Anderegg, Claudia and Antonino, Anca-Teodora and Archanioti, Eva and Arrigoni, Eviano and Bakker de Jong, Diana and Balsiger, Bruno and Bastürk, Polat and Bauerfeind, Peter and Becocci, Andrea and Belli, Dominique and Bengoa, José M and Biedermann, Luc and Binek, Janek and Blattmann, Mirjam and Boehm, Stephan and Boldanova, Tujana and Borovicka, Jan and Braegger, Christian P and Brand, Stephan and Brügger, Lukas and Brunner, Simon and Bühr, Patrick and Burnand, Bernard and Burk, Sabine and Burri, Emanuel and Buyse, Sophie and Cao, Dahlia-Thao and Carstens, Ove and Criblez, Dominique H and Cunningham, Sophie and D’Angelo, Fabrizia and de Saussure, Philippe and Degen, Lukas and Delarive, Joakim and Doerig, Christopher and Dora, Barbara and Drerup, Susan and Egger, Mara and El-Wafa, Ali and Engelmann, Matthias and Ezri, Jessica and Felley, Christian and Fliegner, Markus and Fournier, Nicolas and Fraga, Montserrat and Franc, Yannick and Frei, Pascal and Frei, Remus and Fried, Michael and Froehlich, Florian and Furlano, Raoul Ivano and Garzoni, Luca and Geyer, Martin and Girard, Laurent and Girardin, Marc and Golay, Delphine and Good, Ignaz and Graf Bigler, Ulrike and Gysi, Beat and Haarer, Johannes and Halama, Marcel and Haldemann, Janine and Heer, Pius and Heimgartner, Benjamin and Helbling, Beat and Hengstler, Peter and Herzog, Denise and Hess, Cyrill and Hessler, Roxane and Heyland, Klaas and Hinterleitner, Thomas and Hirschi, Claudia and Hruz, Petr and Juillerat, Pascal and Khalid-de Bakker, Carolina and Kayser, Stephan and Keller, Céline and Knellwolf (-Grieger), Christina and Knoblauch, Christoph and Köhler, Henrik and Koller, Rebekka and Krieger(-Grübel), Claudia and Künzler, Patrizia and ... and Swiss IBD Cohort Investigators
Nature Medicine, ISSN 1078-8956, 02/2019, Volume 25, Issue 2, pp. 323 - 336
Inflammatory bowel diseases (IBD) can be broadly divided into Crohn’s disease (CD) and ulcerative colitis (UC) from their clinical phenotypes. Over 150 host... 
Phenotypes | Inflammatory bowel diseases | Disease | Medical treatment | Health risks | Antibodies | Tumor necrosis factor-α | Fatty acids | Patients | Microorganisms | Replicating | Intestine | Disturbances | Remission | Ulcerative colitis
Journal Article
by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Arozena, Abraham Acevedo and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Algül, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexandru and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sandro and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and An, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Andreadi, Catherine K and Andrieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailendra and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexandre and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Azad, Neelam and Awale, Suresh and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-Sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ...
Autophagy, ISSN 1554-8627, 01/2016, Volume 12, Issue 2, p. 443
Journal Article
2012, ISBN 9781447140139, 423
Book
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2017, Volume 114, Issue 31, pp. 8342 - 8347
Journal Article
Phys. Chem. Chem. Phys, ISSN 1463-9076, 2014, Volume 16, Issue 5, pp. 1820 - 1823
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2019, Volume 17, Issue 10, pp. 2050 - 2059.e1
Background & AimsInflammatory bowel disease (IBD) scoring systems combine patient-reported data with physicians’ observations to determine patient outcomes,... 
Gastroenterology and Hepatology | Disease Activity Index | Management | PRO | SF-36 | ULCERATIVE-COLITIS | VALIDATION | ADULTS | HARVEY-BRADSHAW INDEX | PAIN | MEDICAL THERAPY | EFFICACY END-POINTS | CLINICAL-TRIALS | GASTROENTEROLOGY & HEPATOLOGY | REMISSION | Medical personnel | Medical care | Analysis | Patient outcomes | Ulcerative colitis | Quality management
Journal Article
SWISS MEDICAL WEEKLY, ISSN 1424-7860, 12/2019, Volume 149, p. w20148
Biologics are effective and have a good safety profile in the treatment of inflammatory bowel disease. Biosimilars have recently become available as treatment... 
ORIGINATOR INFLIXIMAB | INNOVATOR INFLIXIMAB | biologics | INFLIXIMAB CT-P13 | CROHNS-DISEASE | ULCERATIVE-COLITIS | ADVERSE DRUG-REACTIONS | inflammatory bowel disease | MEDICINE, GENERAL & INTERNAL | INDUCTION THERAPY | biosimilars | DOUBLE-BLIND | LONG-TERM EFFICACY | CLINICAL-OUTCOMES
Journal Article